Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 200mcg BID Mometasone Furoate Nasal Spray (MFNS) Versus Placebo as Adjunctive Treatment to Antibiotics in Relief of Symptoms of Acute Bacterial Sinusitis

NCT00423176 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00423176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00423176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 200mcg BID Mometasone Furoate Nasal Spray (MFNS) Versus Placebo as Adjunctive Treatment to Antibiotics in Relief of Symptoms of Acute Bacterial Sinusitis
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2006
Completion date
June 30, 2008
Enrollment
237 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sinusitis